◼ Archived
Business
🔮 fades ✓
Alnylam’s heart drug troubles take center stage at a cardiology conference
AstraZeneca's failed heart disease drug trial casts doubt on a promising class of treatments
Gene Silencing
2 independently detected trends connected to this subject, with the latest coverage first.
What Archynetys tracks about Gene Silencing
This hub groups 2 separate news trends connected to Gene Silencing, spanning August 10, 2026 through August 28, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 15 article observations and 13 source signals, led by Business coverage. Use it to compare how individual events emerged, spread and changed over time.
◼ Archived
Business
🔮 fades ✓
Silence Therapeutics aims at Takeda with new data in rare blood cancer
Silence Therapeutics' new data on a rare blood cancer drug could disrupt Takeda's market position.